通过实验和网络药理研究探讨葵花籽油抗阿尔茨海默病的作用机制。

IF 2.4 4区 医学 Q2 Medicine
the Indian Journal of Pharmacy Pub Date : 2024-11-01 Epub Date: 2025-02-19 DOI:10.4103/ijp.ijp_761_23
Yashodhan Desai, Deepak Karunakaran, Juhi Singh, Alric Raul Noronha, Gagan Poojary, Bijaya Chettri, Rekha Shenoy, Madhavan Nampoothiri, Sree Lalitha Bojja
{"title":"通过实验和网络药理研究探讨葵花籽油抗阿尔茨海默病的作用机制。","authors":"Yashodhan Desai, Deepak Karunakaran, Juhi Singh, Alric Raul Noronha, Gagan Poojary, Bijaya Chettri, Rekha Shenoy, Madhavan Nampoothiri, Sree Lalitha Bojja","doi":"10.4103/ijp.ijp_761_23","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>With the prevalence of Alzheimer's disease (AD) increasing exponentially, there has been a shift in the focus of drug discovery for AD from treating the symptoms to preventing the development of the disease. Several natural compounds are extensively studied as neuroprotectives in preventing disease progression. Helianthus annuus seed oil (HA) is widely used as cooking oil and is abundant in antioxidant activity. Therefore, we evaluated the effect of HA in mice model of scopolamine-induced amnesia and explored the potential underlying mechanisms.</p><p><strong>Methods: </strong>Twenty-four male mice were administered orally with either distilled water (control and scopolamine groups) or treatment groups (HA 100 and HA 200 mg/kg) for 8 consecutive days. All groups, except the control group, received an intraperitoneal injection of scopolamine at a dose of 1 mg/kg. Subsequently, novel object recognition task for cognition assessment and open field tests for locomotory activity were performed. In addition, network analysis was performed to identify the key bioactives and targets of HA against AD. Further, the binding affinity of HA bioactives to the key targets was verified by molecular docking analysis.</p><p><strong>Results: </strong>HA (100 mg/kg and 200 mg/kg) significantly ameliorated recognition memory compared to the scopolamine group, suggesting the protective effect of HA against cognitive impairment. Network analysis indicated that the key bioactives of HA, chlorogenic acid, and oleic acid act through multiple targets and pathways, particularly the mitogen-activated protein kinase (MAPK) pathway, to ameliorate AD symptoms. Importantly, chlorogenic acid showed good binding affinity with MAPKs, TP53, and EP300.</p><p><strong>Conclusion: </strong>HA has therapeutic benefits in AD acting through the MAPK pathway. However, further studies need to be done to confirm the results derived and translate the potential use of HA as a dietary supplement for preventing AD.</p>","PeriodicalId":49189,"journal":{"name":"the Indian Journal of Pharmacy","volume":"56 6","pages":"396-404"},"PeriodicalIF":2.4000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11913338/pdf/","citationCount":"0","resultStr":"{\"title\":\"Exploring the mechanism of sunflower seed oil against Alzheimer's disease through experimental and network pharmacology studies.\",\"authors\":\"Yashodhan Desai, Deepak Karunakaran, Juhi Singh, Alric Raul Noronha, Gagan Poojary, Bijaya Chettri, Rekha Shenoy, Madhavan Nampoothiri, Sree Lalitha Bojja\",\"doi\":\"10.4103/ijp.ijp_761_23\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>With the prevalence of Alzheimer's disease (AD) increasing exponentially, there has been a shift in the focus of drug discovery for AD from treating the symptoms to preventing the development of the disease. Several natural compounds are extensively studied as neuroprotectives in preventing disease progression. Helianthus annuus seed oil (HA) is widely used as cooking oil and is abundant in antioxidant activity. Therefore, we evaluated the effect of HA in mice model of scopolamine-induced amnesia and explored the potential underlying mechanisms.</p><p><strong>Methods: </strong>Twenty-four male mice were administered orally with either distilled water (control and scopolamine groups) or treatment groups (HA 100 and HA 200 mg/kg) for 8 consecutive days. All groups, except the control group, received an intraperitoneal injection of scopolamine at a dose of 1 mg/kg. Subsequently, novel object recognition task for cognition assessment and open field tests for locomotory activity were performed. In addition, network analysis was performed to identify the key bioactives and targets of HA against AD. Further, the binding affinity of HA bioactives to the key targets was verified by molecular docking analysis.</p><p><strong>Results: </strong>HA (100 mg/kg and 200 mg/kg) significantly ameliorated recognition memory compared to the scopolamine group, suggesting the protective effect of HA against cognitive impairment. Network analysis indicated that the key bioactives of HA, chlorogenic acid, and oleic acid act through multiple targets and pathways, particularly the mitogen-activated protein kinase (MAPK) pathway, to ameliorate AD symptoms. Importantly, chlorogenic acid showed good binding affinity with MAPKs, TP53, and EP300.</p><p><strong>Conclusion: </strong>HA has therapeutic benefits in AD acting through the MAPK pathway. However, further studies need to be done to confirm the results derived and translate the potential use of HA as a dietary supplement for preventing AD.</p>\",\"PeriodicalId\":49189,\"journal\":{\"name\":\"the Indian Journal of Pharmacy\",\"volume\":\"56 6\",\"pages\":\"396-404\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2024-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11913338/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"the Indian Journal of Pharmacy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.4103/ijp.ijp_761_23\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/2/19 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"the Indian Journal of Pharmacy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4103/ijp.ijp_761_23","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/19 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

随着阿尔茨海默病(AD)的患病率呈指数级增长,阿尔茨海默病药物开发的重点已经从治疗症状转向预防疾病的发展。一些天然化合物作为预防疾病进展的神经保护剂被广泛研究。向日葵籽油(HA)具有丰富的抗氧化活性,被广泛用作食用油。因此,我们评估了透明质酸在东莨菪碱致健忘症小鼠模型中的作用,并探讨了其可能的潜在机制。方法:24只雄性小鼠分别口服蒸馏水(对照组和东莨菪碱组)和治疗组(HA 100和HA 200 mg/kg),连续8 d。除对照组外,其余各组均腹腔注射东莨菪碱,剂量为1mg /kg。随后,进行了新的认知评估目标识别任务和运动活动开放场测试。此外,通过网络分析确定了HA抗AD的关键生物活性和靶点。此外,通过分子对接分析验证了HA生物活性物质与关键靶点的结合亲和力。结果:与东莨菪碱组相比,透明质酸(100 mg/kg和200 mg/kg)显著改善了认知记忆,提示透明质酸对认知障碍有保护作用。网络分析表明,透明质酸、绿原酸和油酸等关键生物活性物质通过多种靶点和途径,特别是通过丝裂原活化蛋白激酶(MAPK)途径,来改善AD症状。重要的是,绿原酸显示出与MAPKs、TP53和EP300良好的结合亲和力。结论:透明质酸通过MAPK通路对AD有治疗作用。然而,需要进一步的研究来证实得出的结果,并转化透明质酸作为预防AD的膳食补充剂的潜在用途。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Exploring the mechanism of sunflower seed oil against Alzheimer's disease through experimental and network pharmacology studies.

Objectives: With the prevalence of Alzheimer's disease (AD) increasing exponentially, there has been a shift in the focus of drug discovery for AD from treating the symptoms to preventing the development of the disease. Several natural compounds are extensively studied as neuroprotectives in preventing disease progression. Helianthus annuus seed oil (HA) is widely used as cooking oil and is abundant in antioxidant activity. Therefore, we evaluated the effect of HA in mice model of scopolamine-induced amnesia and explored the potential underlying mechanisms.

Methods: Twenty-four male mice were administered orally with either distilled water (control and scopolamine groups) or treatment groups (HA 100 and HA 200 mg/kg) for 8 consecutive days. All groups, except the control group, received an intraperitoneal injection of scopolamine at a dose of 1 mg/kg. Subsequently, novel object recognition task for cognition assessment and open field tests for locomotory activity were performed. In addition, network analysis was performed to identify the key bioactives and targets of HA against AD. Further, the binding affinity of HA bioactives to the key targets was verified by molecular docking analysis.

Results: HA (100 mg/kg and 200 mg/kg) significantly ameliorated recognition memory compared to the scopolamine group, suggesting the protective effect of HA against cognitive impairment. Network analysis indicated that the key bioactives of HA, chlorogenic acid, and oleic acid act through multiple targets and pathways, particularly the mitogen-activated protein kinase (MAPK) pathway, to ameliorate AD symptoms. Importantly, chlorogenic acid showed good binding affinity with MAPKs, TP53, and EP300.

Conclusion: HA has therapeutic benefits in AD acting through the MAPK pathway. However, further studies need to be done to confirm the results derived and translate the potential use of HA as a dietary supplement for preventing AD.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
the Indian Journal of Pharmacy
the Indian Journal of Pharmacy Pharmacology, Toxicology and Pharmaceutics-Pharmacology
CiteScore
3.60
自引率
4.20%
发文量
53
期刊介绍: Indian Journal of Pharmacology accepts, in English, review articles, articles for educational forum, original research articles (full length and short communications), letter to editor, case reports and interesting fillers. Articles concerning all aspects of pharmacology will be considered. Articles of general interest (e.g. methods, therapeutics, medical education, interesting websites, new drug information and commentary on a recent topic) are also welcome.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信